238 related articles for article (PubMed ID: 8969553)
1. [Adverse effects of low-dose methotrexate therapy in rheumatoid arthritis].
Furuya T; Totokawa S; Nakajima A; Suzuki T; Kashiwazaki S
Ryumachi; 1996 Oct; 36(5):746-52. PubMed ID: 8969553
[TBL] [Abstract][Full Text] [Related]
2. [Untoward effects of low dose methotrexate therapy in rheumatoid arthritis].
Kawabe Y; Eguchi K; Tsuboi M; Kita M; Tsukada T; Takashima H; Mizokami A; Kawakami A; Matsuoka N; Migita K; Nagataki S
Ryumachi; 1996 Jun; 36(3):514-21. PubMed ID: 8779788
[TBL] [Abstract][Full Text] [Related]
3. Sustained cough in methotrexate therapy for rheumatoid arthritis.
Schnabel A; Dalhoff K; Bauerfeind S; Barth J; Gross WL
Clin Rheumatol; 1996 May; 15(3):277-82. PubMed ID: 8793260
[TBL] [Abstract][Full Text] [Related]
4. [Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis].
Okuda Y; Oyama T; Oyama H; Miyamoto T; Takasugi K
Ryumachi; 1995 Aug; 35(4):699-704. PubMed ID: 7482069
[TBL] [Abstract][Full Text] [Related]
5. Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study.
Verstappen SM; Bakker MF; Heurkens AH; van der Veen MJ; Kruize AA; Geurts MA; Bijlsma JW; Jacobs JW;
Ann Rheum Dis; 2010 Jun; 69(6):1044-8. PubMed ID: 19581281
[TBL] [Abstract][Full Text] [Related]
6. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
Gilani ST; Khan DA; Khan FA; Ahmed M
J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
[TBL] [Abstract][Full Text] [Related]
7. Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate.
Dávila-Fajardo CL; Swen JJ; Cabeza Barrera J; Guchelaar HJ
Pharmacogenomics; 2013 Jan; 14(1):63-73. PubMed ID: 23252949
[TBL] [Abstract][Full Text] [Related]
8. [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis].
Ohosone Y; Okano Y; Kameda H; Hama N; Matsumura M; Nojima T; Nakamura K; Kuwana M; Ogasawara T; Hirakata M; Yoshida T; Mimori T; Akizuki M; Ikeda Y
Ryumachi; 1997 Feb; 37(1):16-23. PubMed ID: 9128419
[TBL] [Abstract][Full Text] [Related]
9. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial comparing 2 different starting doses of methotrexate in rheumatoid arthritis.
Dhir V; Singla M; Gupta N; Goyal P; Sagar V; Sharma A; Khanna S; Singh S
Clin Ther; 2014 Jul; 36(7):1005-15. PubMed ID: 24976447
[TBL] [Abstract][Full Text] [Related]
11. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
Amital H; Arnson Y; Chodick G; Shalev V
Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety of methotrexate in the treatment of rheumatoid arthritis.
Yazici Y
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S65-7. PubMed ID: 21044436
[TBL] [Abstract][Full Text] [Related]
13. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
[TBL] [Abstract][Full Text] [Related]
15. Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
Calvo-Romero JM
Ann Pharmacother; 2001 Dec; 35(12):1575-7. PubMed ID: 11793624
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; James J; Frampton C; Barclay ML
Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
[TBL] [Abstract][Full Text] [Related]
17. [A clinical trial of low dose methotrexate therapy in patients with rheumatoid arthritis].
Nagaoka S; Nakamura M; Senuma A; Sekiguchi A
Nihon Rinsho Meneki Gakkai Kaishi; 2005 Dec; 28(6):389-97. PubMed ID: 16394642
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort.
Shimizu Y; Nakajima A; Inoue E; Shidara K; Sugimoto N; Seto Y; Tanaka E; Momohara S; Taniguchi A; Yamanaka H
Clin Rheumatol; 2017 Jun; 36(6):1237-1245. PubMed ID: 28455827
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis.
Hoekstra M; van Ede AE; Haagsma CJ; van de Laar MA; Huizinga TW; Kruijsen MW; Laan RF
Ann Rheum Dis; 2003 May; 62(5):423-6. PubMed ID: 12695153
[TBL] [Abstract][Full Text] [Related]
20. The time course of gastric methotrexate intolerance in patients with rheumatoid arthritis and psoriatic arthritis.
Dalkilic E; Sahbazlar M; Gullulu M; Yavuz M; Dilek K; Ersoy A; Ozkaya G; Yurtkuran M
Mod Rheumatol; 2013 May; 23(3):525-8. PubMed ID: 22752502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
